NASDAQ:CUE
Cue Biopharma, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.cuebiopharma.comipo date
Jan 02, 2018
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cel...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus